Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SMAD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TRIP12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MED14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SACS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADCY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIMM17A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MINA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGFG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NTRK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSX2IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGTPBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2V2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDZD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OPA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on